GAS5 and acute lymphoblastic leukemia: In the present study, we have analyzed GAS5 levels in BM samples of chB-ALL patients and normal controls in order to evaluate GAS5 lncRNA’s clinical impact on chB-ALL prognosis and prediction of treatment response.